NEA Management Company, LLC Long-Term Concentrated

CIK: 0001512848 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 10, 2017

Total Value ($000): $2,875,271 (100.0% shares, 0.0% debt)

Holdings (38)

TESARO INC 55.0%
Value ($000) $1,581,032 Shares 10,275,113 Est. Cost $34.30 Unrealized
ARDX ARDELYX INC 6.2%
Value ($000) $178,157 Shares 14,083,582 Est. Cost $12.70 Unrealized +3.6%
ACHAOGEN INC 4.6%
Value ($000) $131,578 Shares 5,215,128 Est. Cost $4.67 Unrealized
DERMIRA INC 4.2%
Value ($000) $119,612 Shares 3,506,649 Est. Cost $15.35 Unrealized
EPIZYME INC 3.7%
Value ($000) $107,374 Shares 6,260,851 Est. Cost $24.91 Unrealized
RA PHARMACEUTICALS INC 2.6%
Value ($000) $74,380 Shares 3,493,636 Est. Cost $15.19 Unrealized
CRSP CRISPR THERAPEUTICS AG 2.4%
Value ($000) $70,115 Shares 3,220,728 Est. Cost $18.69 Unrealized +5.1%
ADAPY ADAPTIMMUNE THERAPEUTICS PLC 2.3%
Value ($000) $66,263 Shares 12,025,999 Est. Cost $7.66 Unrealized
GROUPON INC 2.1%
Value ($000) $59,173 Shares 15,056,822 Est. Cost $8.55 Unrealized
SENSEONICS HOLDINGS INC 1.6%
Value ($000) $47,086 Shares 26,305,286 Est. Cost $2.86 Unrealized
GLYCOMIMETICS INC 1.6%
Value ($000) $46,612 Shares 8,584,128 Est. Cost $16.33 Unrealized
CARE COM INC 1.4%
Value ($000) $40,795 Shares 3,260,989 Est. Cost $8.15 Unrealized
CASCADIAN THERAPEUTICS INC 1.3%
Value ($000) $37,527 Shares 9,064,575 Est. Cost $4.17 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 1.2%
Value ($000) $35,294 Shares 4,808,483 Est. Cost $3.61 Unrealized +28.0%
OBSEVA SA 1.2%
Value ($000) $34,734 Shares 3,336,563 Est. Cost $10.41 Unrealized
LXRX LEXICON PHARMACEUTICALS INC 1.2%
Value ($000) $34,162 Shares 2,382,286 Est. Cost $12.29 Unrealized +20.7%
NEVRO CORP 1.2%
Value ($000) $33,702 Shares 359,678 Est. Cost $38.67 Unrealized
PROTEOSTASIS THERAPEUTICS INC 1.0%
Value ($000) $27,814 Shares 3,556,778 Est. Cost $10.41 Unrealized
STRONGBRIDGE BIOPHARMA PLC 0.7%
Value ($000) $19,671 Shares 4,141,308 Est. Cost $5.09 Unrealized
AEROHIVE NETWORKS INC 0.6%
Value ($000) $18,144 Shares 4,309,691 Est. Cost $8.02 Unrealized
ENDOLOGIX INC 0.6%
Value ($000) $18,029 Shares 2,490,204 Est. Cost $8.36 Unrealized
TREVENA INC 0.5%
Value ($000) $13,989 Shares 3,811,691 Est. Cost $7.47 Unrealized
RIGEL PHARMACEUTICALS INC 0.4%
Value ($000) $10,375 Shares 3,243,150 Est. Cost $3.34 Unrealized
TRACON PHARMACEUTICALS INC 0.4%
Value ($000) $10,347 Shares 2,759,217 Est. Cost $11.16 Unrealized
AVEO PHARMACEUTICALS INC 0.3%
Value ($000) $9,654 Shares 16,362,694 Est. Cost $0.82 Unrealized
AFFIMED NV 0.3%
Value ($000) $8,944 Shares 3,888,888 Est. Cost $2.30 Unrealized
MIRNA THERAPEUTICS INC 0.2%
Value ($000) $6,515 Shares 2,974,811 Est. Cost $6.25 Unrealized
DASAN ZHONE SOLUTIONS INC 0.2%
Value ($000) $5,972 Shares 956,255 Est. Cost $6.25 Unrealized
SUNESIS PHARMACEUTICALS INC 0.2%
Value ($000) $5,323 Shares 1,298,274 Est. Cost $4.37 Unrealized
AKARI THERAPEUTICS PLC 0.2%
Value ($000) $5,005 Shares 452,167 Est. Cost $13.49 Unrealized
CSBR CHAMPIONS ONCOLOGY INC 0.2%
Value ($000) $4,953 Shares 1,562,500 Est. Cost $6.08 Unrealized -42.5%
ARCA BIOPHARMA INC 0.1%
Value ($000) $3,724 Shares 1,460,209 Est. Cost $4.96 Unrealized
ROKA BIOSCIENCE INC 0.1%
Value ($000) $3,181 Shares 893,471 Est. Cost $4.24 Unrealized
ARQULE INC 0.1%
Value ($000) $2,672 Shares 2,520,316 Est. Cost $2.32 Unrealized
OREXIGEN THERAPEUTICS INC 0.0%
Value ($000) $1,276 Shares 370,900 Est. Cost $3.32 Unrealized
PARATEK PHARMACEUTICALS INC 0.0%
Value ($000) $1,275 Shares 66,245 Est. Cost $38.55 Unrealized
CATALYST BIOSCIENCES INC 0.0%
Value ($000) $410 Shares 43,492 Est. Cost $9.43 Unrealized
CERECOR INC 0.0%
Value ($000) $402 Shares 595,435 Est. Cost $2.01 Unrealized